![Spectrum Pharmaceuticals, Inc.](https://microsmallcap.com/wp-content/uploads/2017/10/The-Road-Ahead-for-Spectrum-Pharmaceuticals-374x295.jpg)
Biotechnology
The Road Ahead for Spectrum Pharmaceuticals, Inc.
Spectrum Pharmaceuticals, Inc. (NASDAQ:$SPPI) experienced a disappointing day during trading on Monday, September 18. The stock dipped -0.69% to a closing price of $10.10. The stock normally trades 894.52 million shares a day, but on ... [Read]
Biotechnology
The Recipe Behind Abeona Therapeutics’ 6 Months Dominance
As of 2:50 EDT, Abeona Therapeutics (NASDAQ:$ABEO) have surged a whopping 18%. This came after an analyst from RBC Capital granted the biotech company an outperform rating and assigned a $23 price target, more than ... [Read]
![VBI Vaccines](https://microsmallcap.com/wp-content/uploads/2017/10/Here-is-What-You-Need-to-Measure-VBI-Vaccines-Incs-Momentum--374x295.jpg)
Biotechnology
Here is What You Need to Measure VBI Vaccines Inc.’s Momentum
As of morning trading, VBI Vaccines Inc. (NASDAQ:$VBIV) shares are revealing a strong upward momentum, with the Aroon indicator reading above 70. Many investors are intrigued. Let’s look at the different metrics of measurement used ... [Read]
![Rating for Spectrum Pharmaceuticals](https://microsmallcap.com/wp-content/uploads/2017/10/Trilogy-Metals-Inc-Enters-Active-Mover-List.-374x295.jpg)
Biotechnology
Analysts’ September Coverage Rating for Spectrum Pharmaceuticals
Spectrum Pharmaceuticals, Inc. (NASDAQ:$SPPI) is a biotechnology company with a market cap of $857.70 million. The company specialized in the development and commercialization of oncology and hematology drugs. Despite operating through negative earnings currently, Spectrum ... [Read]
Biotechnology
Intercept Pharmaceuticals Stock Is Falling Today, Here’s Why
As of 10:30 a.m. EDT, shares of Intercept Pharmaceuticals (NASDAQ:$ICPT) declined by 17%. Why? Many speculate the fall was caused by a letter that was sent by Intercept’s Chief Medical Officer to the medical community ... [Read]
Biotechnology
Here’s Why Immune Design is Down 6.8% Since the Last Earnings Report
Plummeting 6.8%, way outperforming the market, Immune Design Corp. (NASDAQ:$IMDZ)’s shares are suffering a serious outlook. Let’s take a look back on Immune Design’s last earnings report. Narrower-than-expected Loss in Q2 The company incurred 2Q17 ... [Read]
Biotechnology
The Market Empties On Otonomy Inc. Stock
Following truly abysmal results from a pivotal Phase 3 trial for its steroid candidate Otividex, Otonomy Inc. (NASDAQ:$OTIC) saw its investors parachuting out of their shares. The number? A cool 81.5% decrease. While about 600,000 ... [Read]
Biotechnology
Cara Therapeutics Stock Increases After Revealing Promising Data From a Phase 1 Drug Trial
On Wednesday, Cara Therapeutics (NASDAQ:$CARA) stock increased after the biotech company revealed promising data from a Phase 1 drug trial for chronic kidney disease patients. If you’re a biotech investor, you are probably aware of ... [Read]
Biotechnology
Celsion Corp’s Stock Increased Almost 25% Today
On Wednesday, July 5, in a morning trading session, shares of Celsion Corp. (NASDAQ:$CLSN) increased almost 25% to $2.53. This jump occurred after the New Jersey-based firm disclosed the completion of the Ovation study, a ... [Read]
Biotechnology
A British Biotech Company is Close to a Breakthrough Blood Test for Diagnosing Ovarian Cancer
On Monday, U.K-based biotech company Angle plc (OTCQX:$ANPCY) disclosed the trial results of a possible breakthrough blood test for diagnosing ovarian cancer. Essentially, Angle’s blood test could allow for a quicker diagnosis and referral for women ... [Read]